Loss of expression of protein kinase C β is a common phenomenon in human malignant melanoma: A result of transformation or differentiation?

Melanoma Research

Volumn 11, Issue 4, 2001, Pages 355-369

  Gilhooly, E M ^a   Morse Gaudio, M ^a   Bianchi, L ^a   Reinhart, L ^a   Rose, D P ^a   Connolly, J M ^a   Reed, J A ^b   Albino, A P ^a  

^a AMERICAN HEALTH FOUNDATION   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Melanocytes; Metastatic melanoma cell lines; Protein kinase C

Indexed keywords

ISOENZYME; MESSENGER RNA; PROTEIN KINASE C;

ARTICLE; CANCER CELL CULTURE; CELL DIFFERENTIATION; CELL INVASION; CELL STRUCTURE; ENZYME ACTIVATION; ENZYME LOCALIZATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALIGNANT TRANSFORMATION; MELANOCYTE; MELANOMA; MELANOMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

BLOTTING, WESTERN; CELL DIFFERENTIATION; CELL EXTRACTS; CELL LINE; CELL MEMBRANE; CELL SIZE; CELL TRANSFORMATION, NEOPLASTIC; CYTOSOL; DOWN-REGULATION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; ISOENZYMES; MELANOCYTES; MELANOMA; NEOPLASM INVASIVENESS; PROTEIN KINASE C; PROTEIN TRANSPORT; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, NEOPLASM; TUMOR CELLS, CULTURED;

EID: 0034902972     PISSN: 09608931     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008390-200108000-00006     Document Type: Article

References (65)

1. Epidemiological aspects of cutaneous malignant melanoma
2. Molecular biology of malignant melanoma
3. Molecular events in melanoma development and progression
4. Neoplastic progression and prognosis in melanoma
5. Biology of tumor progression in human melanocytes
6. Selective proliferation of normal human melanocytes in vitro in the presence of phorbol esters and cholera toxin
7. Stimulation of growth of human melanocytes by tumor promoters
8. Tumor progression in the human melanocytic system
9. Human melanocytes cultured from nevi and melanomas
10. Growth inhibition of human melanoma-derived cells by 12-O-tetradecanoyl phorbol 13-acetate
11. Regulation of the cell cycle at the G2/M boundary in metastatic melanoma cells by 12-O-tetradecanoyl phorbol-13-acetate (TPA) by blocking p34cdc2 kinase activity
12. Deletion of specific protein kinase C subspecies in human melanoma cells
13. Differential induction of 12-O-tetradecanoyl phorbol-13 acetate gene expression in murine melanocytes and melanoma cells
14. Growth of human melanocyte cultures supported by 12-O-tetradecanoyl-phorbol-13-acetate is mediated through protein kinase C activation
15. Selective involvement of protein kinase C isozymes in differentiation and neoplastic transformation
16. PKCμ is a novel, atypical member of the protein kinase C family
17. Protein kinase C isoenzymes: Regulation and function
18. The role of PKC in the evolution and proliferation of malignant gliomas, and the application of PKC inhibition as a novel approach to antiglioma therapy
19. Protein kinase C beta expression in melanoma cells and melanocytes: Differential expression correlates with biological responses to 12-O-tetradecanoylphorbol 13-acetate
20. Surface antigens of melanocytes and melanomas. Markers of melanocyte differentiation and melanoma subsets
21. Class II histocompatibility antigen expression in human melanocytes transformed by Harvey murine sarcoma virus (Ha-MSV) and Kirsten MSV retroviruses
22. Surface antigens of melanomas and melanocytes defined by mouse monoclonal antibodies: Specificity analysis and comparison of antigen expression in cultured cells and tissues
23. Mutation and expression of the p53 gene in human malignant melanoma
24. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedures and applications
25. Complete one-hour immunocytochemistry based on capillary action
26. Growth inhibition of human melanoma-derived cells by 12-O-tetradecanoyl phorbol 13-acetate
27. Protein kinase C beta expression in melanoma cells and melanocytes: Differential expression correlates with biological responses to 12-O-tetradecanoylphorbol 13-acetate
28. Alterations in gene expression and signal transductions in human melanocytes and melanoma cells
29. PKC-dependent modulation of IkB alpha-NFkB pathway in low metastatic B16F1 murine melanoma cells and in highly metastatic BL6 cells
30. Alternative splicing increases the diversity of the human protein kinase C family
31. Nucleotide sequence of the 3′ portion of a human gene for protein kinase C betaI/beta II
32. Human melanoma metastasis is inhibited following ex vivo treatment with an antisense oligonucleotide to protein kinase C-alpha
33. Effect of protein kinase C inhibitors on invasiveness of human melanoma clones expressing different levels of protein kinase C isoenzymes
34. The pleiotropic effect of TPA on in vitro invasion/migration of glioma and melanoma cell lines
35. Differential expression of protein kinase C and cAMP-dependent protein kinase in normal human melanocytes and malignant melanomas
36. The differential expression of protein kinase C genes in normal human neonatal melanocytes and metastatic melanomas
37. Elucidation of the exon-intron structure and size of the human protein kinase C beta gene (PRKCB)
38. The extended protein kinase C superfamily
39. A derivative of staurosporine (CGP 41 251) shows selectivity for protein kinase C inhibition and in vitro anti-proliferative as well as in vivo anti-tumor activity
40. Effect of protein kinase activating tumor promoters on metastases formation by fibrosarcoma cells
41. The effect of phorbol ester treatment on migration of C3H 10T1/2 and BT5C glioma cells: Possible application to carcinogenesis
42. 2 activate p57 mitogen-activated protein kinase and block differentiation in colon carcinoma cells
43. Inhibition of invasion of invasive human bladder carcinoma cells by protein kinase C inhibitor Staurosporine
44. Protein kinase C: A novel target for inhibiting gastric cancer cell invasion
45. Critical factors in the biology of human cancer metastasis
46. Breast cancer cell invasiveness and differential regulation by phorbol ester in estrogen receptor-positive and -negative cells
47. Differential expression of protein kinase C isoforms in human colorectal cancers
48. Overexpression of protein kinase C beta 1 in the SW480 colon cancer cell line causes growth suppression
49. Induction of a less aggressive breast cancer phenotype by protein kinase C-α and -β overexpression
50. II
51. Overproduction of protein kinase C causes disordered growth control in rat fibroblasts
52. 2 induces colonic hyperproliferation and increased sensitivity to colon carcinogenesis
53. Neurofibromas and neurotized melanocytic nevi are immunohistochemically distinct neoplasms
54. Ultrastructural heterogeneity of acquired intradermal melanocytic nevus cells
55. The intermediate filament peripherin is expressed in cutaneous melanocytic lesions
56. Divergent cellular differentiation pathways during the invasive stage of cutaneous malignant melanoma progression
57. Protein kinase C-beta activates tyrosinase by phosphorylating serine residues in its cytoplasmic domain
58. Alpha-melanocyte stimulating hormone-induced pigmentation is blocked by depletion of protein kinase C
59. Decreased expression of Type II protein kinase C in HL-60 variant cells resistant to induction of cell differentiation by phorbol ester
60. 1α,25-Dihydroxyvitamin D3-induced regulation of protein kinase C gene expression during HL-60 cell differentiation
61. Protein kinase C during differentiation of human promyelocytic leukemia cell line, HL-60
62. Critical targets of protein kinase C in differentiation of tumour cells
63. Regulation of melanin synthesis of B16 mouse melanoma cells by 1α,25-dihydroxyvitamin D3 and retinoic acid
64. Overexpression of novel protein kinase C δ in BL6 murine melanoma cells inhibits the proliferative capacity in vitro but enhances the metastatic potential in vivo
65. Identification of the protein kinase C isoenzymes in human lung and airway smooth muscle at the protein and mRNA level